The Recall Desk

Agency

U.S. Food and Drug Administration

The FDA regulates food, drugs, biologics, medical devices, and tobacco. We aggregate Class I, II, and III enforcement actions across its three recall streams.

Visit the official FDA site →

About FDA recalls

The FDA is the single biggest source of US product recalls by volume. Its enforcement workload splits into three streams — Foods (everything from infant formula to leafy greens to nutritional supplements), Drugs (prescription medicines, over-the-counter products, and active pharmaceutical ingredients), and Medical Devices (everything from implants to home blood-pressure monitors). The Recall Desk ingests all three from the openFDA enforcement endpoint every six hours.

FDA classifies every recall as Class I, II, or III. Class I means there is a reasonable probability that using the product will cause serious health consequences or death — these are the recalls you should treat as urgent. Class II means the product may cause temporary or medically reversible harm. Class III means the product is unlikely to cause adverse health consequences but still violates FDA rules. We map these classifications into our 1–5 severity score using the rubric on the methodology page.

Medical-device recalls are the highest-volume stream by far — software-update letters, calibration corrections, and IFU updates all show up in enforcement reports alongside genuine hazard recalls. We try to surface the severe ones first, but when in doubt, click through to the FDA notice itself for the clinical detail.

39976–40000 of 88304

  • SevereFDA (Devices)·Z-1770-2019·2019-07-17

    Becton Dickinson Recalls Alaris Pump Infusion Sets Due to Occlusion Defect

    Becton Dickinson is recalling Alaris Pump Infusion Sets because a wall thickness variation can cause incomplete occlusion, potentially leading to unintended or faster-than-expected medication delivery.

    Product
    Alaris Pump Infusion Set, Model Codes 10010453, 10010454, 10012144, 10015294, 10015414, 10933805, 11171447, 11404930, 11522558, 11607704, 10013361T, 2110-0500, 2126-0500, 2200-0500, 2411-0500, 2419-0007, 2420-0007, 2420-0500, 2421-0500, 2426-0007, 2426-0500, 2429-0500…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-1847-2019·2019-07-17

    GE Healthcare Recalls Panda Infant Radiant Warmers Due to Bedside Panel Cracking

    GE Healthcare is recalling 28,094 Panda Infant Radiant Warmers because the bedside panels and latch areas can crack or break if the unit is moved using them instead of the designated handles.

    Product
    Panda Infant Radiant Warmer Infant radiant warmers provide infrared heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Infant radiant warmers may be used to facilitate the neonate's transition to the external environment…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1472-2019·2019-07-17

    Testosterone Cypionate Injection Recalled for Sterility Assurance Concerns

    First Pharma Associates is recalling Testosterone Cypionate 100 mg/mL oil injections due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    Testosterone Cypionate 100 mg/mLOil Injection Injection, 12 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1476-2019·2019-07-17

    Hydroxocobalamin Injection Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling Hydroxocobalamin 10 mg/mL Injection due to a lack of assurance of sterility. The product is distributed in Idaho and Washington.

    Product
    Hydroxocobalamin 10 mg/mL Injection (ALT) Solution, 30 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1455-2019·2019-07-17

    Teva Recalls Losartan Potassium Tablets Due to Impurity Detection

    Teva Pharmaceuticals USA is recalling Losartan Potassium 50 mg tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1460-2019·2019-07-17

    Macleods Pharma Recalls Losartan Potassium and Hydrochlorothiazide Tablets Due to Impurity

    Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active pharmaceutical ingredient.

    Product
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1481-2019·2019-07-17

    FDA Recalls Riverpoint Pharmacy Injection Due to Sterility Concerns

    First Pharma Associates LLC dba Riverpoint Pharmacy is recalling PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    PAP/PHEN/PGE1 30 mg/0.83mg/10mcg/mL Injection, 5 mL, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1466-2019·2019-07-17

    Major Pharmaceuticals Recalls Losartan Potassium Tablets Due to Impurity

    Major Pharmaceuticals is recalling Losartan Potassium 50 mg tablets because FDA testing found an impurity above acceptable levels.

    Product
    Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count Unit Dose Cartons. Manufactured by Major Pharmaceuticals 17177 N. Laurel Park Drive Suite 233, Livonia, MI 48152.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1469-2019·2019-07-17

    Testosterone Cypionate Injection Recalled Due to Sterility Concerns

    First Pharma Associates is recalling Testosterone Cypionate 150 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    Testosterone Cypionate 150 mg/mL Sesame Oil Injection, 12 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343- 6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1461-2019·2019-07-17

    Macleods Pharma Recalls Losartan Potassium and Hydrochlorothiazide Tablets Due to Impurity

    Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1480-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates LLC dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility.

    Product
    PAP/PHEN/PGE1 30 mg/2mg/20mcg/mL Injection, 10mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Devices)·Z-1923-2019·2019-07-17

    Philips HeartStart MRx Recall Due to AC Power Module Failure Risk

    Philips is recalling HeartStart MRx devices used with specific AC power modules that may fail, potentially causing loss of power and failure to deliver shocks.

    Product
    Philips HeartStart MRx devices in use with the M3539A AC Power Module: M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3, M3536M4, M3536M5, M3536M6, M3536M7, M3536M8, M3536M9
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1473-2019·2019-07-17

    Riverpoint Pharmacy Recalls Testosterone Cyp/Estradiol Cyp Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific vials of Testosterone Cyp/Estradiol Cyp Injection because of a lack of assurance of sterility.

    Product
    Testosterone Cyp/Estradiol Cyp 50 mg/2.5 mg/mL Injection, 3mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Devices)·Z-1874-2019·2019-07-17

    Hamilton Medical Recalls HAMILTON-G5 Ventilators Due to Ambient State Risk

    Hamilton Medical is recalling 4,338 HAMILTON-G5 ventilators with software versions 2.60 or lower because they may enter an ambient state, requiring immediate alternative ventilation.

    Product
    HAMILTON-G5, with software versions less than or equal to 2.60 The HAMILTON-G5/S1 ventilators are designed for intensive care ventilation of adult and pediatric patients, and optionally infant and neonatal patients. The device is intended for use in the hospital and…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1462-2019·2019-07-17

    Losartan Potassium Tablets Recalled Due to Impurity Detection

    Golden State Medical Supply Inc. is recalling Losartan Potassium 50 mg tablets because an impurity was detected in the active ingredient.

    Product
    Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1464-2019·2019-07-17

    Losartan Potassium Tablets Recalled Due to Nitrosamine Impurity

    Golden State Medical Supply is recalling Losartan Potassium 50 mg tablets because a nitrosamine impurity was detected in the active ingredient.

    Product
    Losartan Potassium, 50 mg tablets, 1000 count bottle, NDC 60429-317-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1479-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection because the sterility of the product cannot be assured.

    Product
    PAP/PHEN/PGE1 22 mg/0.8mg/8mcg/mL Injection, 5mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1458-2019·2019-07-17

    Macleods Pharma Recalls Losartan Potassium Tablets Due to Impurity

    Macleods Pharma USA Inc. is recalling Losartan Potassium 50 mg tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM — LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-1846-2019·2019-07-17

    GE Healthcare Recalls Giraffe Infant Radiant Warmers Due to Panel Cracking

    GE Healthcare is recalling 9,094 Giraffe Infant Radiant Warmers because bedside panels and latch areas can crack or break if the unit is moved using the panels instead of the designated handles.

    Product
    Giraffe Infant Radiant Warmer Infant radiant warmers provide infrared heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Infant radiant warmers may be used to facilitate the neonate's transition to the external environment…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1474-2019·2019-07-17

    FDA Recalls Hydroxyprogesterone Caproate Injection Due to Sterility Concerns

    First Pharma Associates is recalling Hydroxyprogesterone Caproate 250 mg/mL injections due to a lack of assurance of sterility. The recall affects vials distributed in Idaho and Washington.

    Product
    Hydroxyprogesterone Caproate 250 mg/mL Sesame Oil Injection, 5 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1478-2019·2019-07-17

    Methylcobalamin Injection Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling Methylcobalamin 10 mg/mL Injection vials due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.

    Product
    Methylcobalamin 10 mg/mL Injection, 5.4 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1482-2019·2019-07-17

    Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns

    First Pharma Associates dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility.

    Product
    PAP/PHEN/PGE1 18 mg/0.6mg/5.88mcg/mL Injection, 5 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-1456-2019·2019-07-17

    Teva Recalls Losartan Potassium Tablets Due to Impurity Detection

    Teva Pharmaceuticals is recalling Losartan Potassium 100 mg tablets because an impurity was detected in the active ingredient.

    Product
    LOSARTAN POTASSIUM 100 mg TABLET BULK 90 count bottles, NDC 00591-3747-00
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1463-2019·2019-07-17

    Losartan Potassium tablets recalled due to impurity detection

    Golden State Medical Supply Inc. is recalling Losartan Potassium 50 mg tablets because an impurity was detected in the active ingredient.

    Product
    Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1470-2019·2019-07-17

    Testosterone Cypionate Injection Recalled for Lack of Sterility Assurance

    First Pharma Associates is recalling Testosterone Cypionate 200 mg/mL injections due to a lack of assurance of sterility.

    Product
    Testosterone Cypionate 200 mg/mL Sesame Oil Injection, packaged in a) 9 mL, b) 12 mL vials, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343- 6252
    Category
    Drug
    Distribution
    2 states